KPV (Lys-Pro-Val)

KPV is a naturally occurring tripeptide fragment of the larger hormone alpha-melanocyte stimulating hormone (α-MSH). It has been studied for its anti-inflammatory and antimicrobial properties. Unlike full α-MSH, KPV is a small, stable peptide that can be delivered topically, orally, or via injection in research models. It remains experimental and is not FDA-approved for therapeutic use.

How It Is Used in Research Settings

• Explored for anti-inflammatory effects in models of skin irritation, colitis, and systemic inflammation.
• Studied in wound healing and tissue repair research due to its role in reducing inflammatory cytokines.
• Investigated as a potential antimicrobial peptide against certain bacteria and pathogens.
• Examined for skin health applications, including acne, dermatitis, and inflammatory skin conditions.

Proposed Uses (Research Areas)

• Inflammation and immune modulation research.
• Dermatology studies — acne, psoriasis, eczema, and wound healing.
• Gastrointestinal research — colitis and inflammatory bowel disease models.
• General regenerative and protective peptide studies.

How It Is Dosed in Research Settings

• Injectable: Studied at 200–500 mcg subcutaneously daily in inflammation models.
• Topical: Formulated into creams or gels at 0.1%–1% concentrations for skin applications in research settings.
• Oral: Explored in capsule form, though absorption and bioavailability require more validation.
• Cycle length: Research studies typically range from 2–6 weeks depending on endpoints.

Important Considerations

• Regulatory status: KPV is not FDA-approved; all applications remain experimental.
• Evidence base: Most data comes from preclinical animal and cell culture studies; human trials are limited.
• Safety: Reported as well tolerated in research settings, with low toxicity observed in models. Long-term safety in humans is unknown.

Disclaimer

This material is provided for educational purposes only and summarizes published research on KPV.
It is not medical advice. KPV is experimental, not FDA-approved, and should not be viewed as a therapy for medical use.

This peptide is for research use only.